Milestone Pharmaceuticals Inc. - stock earnings
MIST Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -15.1 million USD | ? USD |
| 2023Q2 | -16.0 million USD | ? USD |
| 2023Q1 | -14.4 million USD | 1.0 million USD |
| 2022Q4 | 18.3 million USD | 3.5 million USD |
| 2022Q3 | -14.1 million USD | 1.5 million USD |
| 2022Q2 | -16.5 million USD | ? USD |
| 2022Q1 | -14.0 million USD | ? USD |
| 2021Q4 | -16.9 million USD | 15.0 million USD |
| 2021Q3 | -14.2 million USD | 15.0 million USD |
| 2021Q2 | 770000 USD | 15.0 million USD |
| 2021Q1 | -12.5 million USD | ? USD |
| 2020Q4 | -8.7 million USD | ? USD |
| 2020Q3 | -12.0 million USD | ? USD |
| 2020Q2 | -13.0 million USD | ? USD |
| 2020Q1 | -16.3 million USD | ? USD |
| 2019Q4 | -18.3 million USD | ? USD |
| 2019Q3 | -12.8 million USD | ? USD |
| 2019Q2 | -13.7 million USD | ? USD |
| 2019Q1 | -10.5 million USD | ? USD |
| 2018Q4 | -9.7 million USD | ? USD |
| 2018Q3 | -5.7 million USD | ? USD |
| 2018Q2 | -3.6 million USD | ? USD |
| 2018Q1 | -4.2 million USD | ? USD |
MIST Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.3 million USD | 4.5 million USD |
| 2022 | -57.1 million USD | 5.0 million USD |
| 2021 | -42.6 million USD | 15.0 million USD |
| 2020 | -50.0 million USD | 15.0 million USD |
| 2019 | -55.2 million USD | ? USD |
| 2018 | -23.2 million USD | ? USD |
| 2017 | -8.1 million USD | ? USD |
MIST
Price: $1.70
52 week price:
Earnings Per Share: -1.39 USD
P/E Ratio: -1.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 563278
Market Capitalization: 90.1 million